Specialty Pharma Journal Specialty, Precision & Technology
Amsterdam, The Netherlands: Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma. The findings were presented in two presentations at the European Cancer Congress 2017 [1] today. Until …
Tag Archives: ECCO
January, 2017
March, 2016
-
18 March
Janssen’s Stelara Achieves Primary Endpoint in its Late-Stage Crohn’s Trial
AMSTERDAM, March 18, 2016 /PRNewswire/ — Phase 3 data presented at the 11th Congress of the European Crohn’s and Colitis Organisation (ECCO) showed that treatment with STELARA® (ustekinumab) induced clinical response and clinical remission in adult patients with moderate to severe Crohn’s disease who had previously failed or were intolerant to …
-
11 March
Multi-Gene Test Identifies Early Breast Cancer Patients who can be Spared Chemotherapy
Amsterdam, The Netherlands: Researchers have shown for the first time that it is possible to use a multi-gene test to identify patients with early breast cancer who can be spared chemotherapy and who will still be alive and well five years after diagnosis. New results from the West German Study …